Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

By: TheNewswire.com

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

More News

View More
News headline image
AI Panic Hits Wall Street: 3 Financial Stocks on Sale ↗
Via MarketBeat
Topics Artificial Intelligence
Tickers IBM RJF SCHW SPGI
News headline image
Matador’s Results Were Better Than Feared, But 2026 Headwinds Still Matter ↗
Via MarketBeat
Tickers ET MTDR
News headline image
Despite a Double Miss, D-Wave's Earnings Could Fuel a New Rally ↗
Via MarketBeat
Tickers QBTS
News headline image
Comfort Systems: Strong Earnings and the Case for a Split ↗
Via MarketBeat
Tickers FIX NVDA
News headline image
5 Hot Buys Ready to Spring Higher in March ↗
Via MarketBeat
Tickers ALMU AMD AMPX ELF MU NVDA

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.72
+0.80 (0.38%)
AAPL  269.29
-3.66 (-1.34%)
AMD  200.92
-2.76 (-1.36%)
BAC  49.88
-2.42 (-4.63%)
GOOG  308.37
+1.22 (0.40%)
META  646.10
-10.91 (-1.66%)
MSFT  396.49
-5.24 (-1.30%)
NVDA  181.58
-3.31 (-1.79%)
ORCL  145.26
-5.05 (-3.36%)
TSLA  403.12
-5.45 (-1.34%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.